This book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explained
This book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explainedHinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Patric U. B. Vogel is a biologist with many years of experience with various biopharmaceuticals, from live vaccines to DNA vaccines. He was a registered Qualified Person for several years and has regularly released coronavirus vaccines against animal diseases, among other things. Since 2019, he has been an author, trainer and consultant in the pharmaceutical field.
Inhaltsangabe
Introduction. Coronaviruses: history and viral properties. Vaccine technologies, approaches against COVID 19, clinical phases. Attenuated live vaccines. Vector vaccines and virus like particles. Inactivated vaccines. Recombinant proteins (protein subunits). Nucleic acid based vaccines. Other aspects One vaccine for all? Herd immunity Duration of immunity Sterilizing immunity. Summary.
Introduction.- Coronaviruses: history and viral properties.- Vaccine technologies, approaches against COVID-19, clinical phases.- Attenuated live vaccines.- Vector vaccines and virus-like particles.- Inactivated vaccines.- Recombinant proteins (protein subunits).- Nucleic acid-based vaccines.- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity.- Summary.
Introduction. Coronaviruses: history and viral properties. Vaccine technologies, approaches against COVID 19, clinical phases. Attenuated live vaccines. Vector vaccines and virus like particles. Inactivated vaccines. Recombinant proteins (protein subunits). Nucleic acid based vaccines. Other aspects One vaccine for all? Herd immunity Duration of immunity Sterilizing immunity. Summary.
Introduction.- Coronaviruses: history and viral properties.- Vaccine technologies, approaches against COVID-19, clinical phases.- Attenuated live vaccines.- Vector vaccines and virus-like particles.- Inactivated vaccines.- Recombinant proteins (protein subunits).- Nucleic acid-based vaccines.- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity.- Summary.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497